Literature DB >> 16039335

Safer injection facility use and syringe sharing in injection drug users.

Thomas Kerr1, Mark Tyndall, Kathy Li, Julio Montaner, Evan Wood.   

Abstract

Safer injection facilities provide medical supervision for illicit drug injections. We aimed to examine factors associated with syringe sharing in a community-recruited cohort of illicit injection drug users in a setting where such a facility had recently opened. Between Dec 1, 2003, and June 1, 2004, of 431 active injection drug users 49 (11.4%, 95% CI 8.5-14.3) reported syringe sharing in the past 6 months. In logistic regression analyses, use of the facility was independently associated with reduced syringe sharing (adjusted odds ratio 0.30, 0.11-0.82, p=0.02) after adjustment for relevant sociodemographic and drug-use characteristics. These findings could help inform discussions about the merits of such facilities.

Entities:  

Mesh:

Year:  2005        PMID: 16039335     DOI: 10.1016/S0140-6736(05)66475-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  102 in total

1.  Vancouver's supervised injection facility challenges Canada's drug laws.

Authors:  Kathleen Dooling; Michael Rachlis
Journal:  CMAJ       Date:  2010-08-30       Impact factor: 8.262

2.  Recent incarceration linked to cutaneous injection-related infections among active injection drug users in a Canadian setting.

Authors:  M-J Milloy; Evan Wood; Elisa Lloyd-Smith; Eric Grafstein; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Community Health       Date:  2010-12

3.  Problem recognition, intention to stop use, and treatment use among regular heroin injectors.

Authors:  Rebecca Trenz; Typhanye Penniman; Michael Scherer; Julia Zur; Jonathan Rose; William Latimer
Journal:  J Subst Abuse Treat       Date:  2012-02-01

4.  Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.

Authors:  Evan Wood; Mark W Tyndall; Zhenguo Qui; Ruth Zhang; Julio S G Montaner; Thomas Kerr
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

5.  Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.

Authors:  Evan Wood; Mark W Tyndall; Julio S Montaner; Thomas Kerr
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

6.  Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.

Authors:  Thomas Kerr; Jo-Anne Stoltz; Mark Tyndall; Kathy Li; Ruth Zhang; Julio Montaner; Evan Wood
Journal:  BMJ       Date:  2006-01-28

7.  Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.

Authors:  Sarah Ickowicz; Evan Wood; Huiru Dong; Paul Nguyen; Will Small; Thomas Kerr; Julio S G Montaner; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2017-08-10       Impact factor: 4.492

8.  Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.

Authors:  Mary Clare Kennedy; David C Klassen; Huiru Dong; M-J S Milloy; Kanna Hayashi; Thomas H Kerr
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

9.  Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.

Authors:  Brett Wolfson-Stofko; Luther Elliott; Alex S Bennett; Ric Curtis; Marya Gwadz
Journal:  Int J Drug Policy       Date:  2018-10-22

10.  Community viral load as a measure for assessment of HIV treatment as prevention.

Authors:  William C Miller; Kimberly A Powers; M Kumi Smith; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2013-03-25       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.